Galectin expression profiling identifies galectin-1 and Galectin-9Δ5 as prognostic factors in stage I/II non-small cell lung cancer.

Galectin expression profiling identifies galectin-1 and Galectin-9Δ5 as prognostic factors in stage I/II non-small cell lung cancer.

Approximately 30-40% of the patients with early stage non-small cell lung cancer (NSCLC) will present with recurrent disease within two years of resection. Here, we performed extensive galectin expression profiling in a retrospective study using frozen and paraffin embedded tumor tissues from 87 sta...

Full description

Bibliographic Details
Main Authors: Iris A Schulkens, Roy Heusschen, Vivian van den Boogaart, Robert-Jan van Suylen, Anne-Marie C Dingemans, Arjan W Griffioen, Victor L Thijssen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0107988

Internet

https://doi.org/10.1371/journal.pone.0107988

Similar Items